Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate PRM, a holder of the top 10 US healthcare companies, as a TOP PICK.  The sector continues to be a strong performer and the yield offered is exceptional.  We continue to recommend a stop at $13, looking to achieve $18 -- upside potential of 18%.  Yield 8.3%

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate V as a TOP PICK.  The company is seeking a stablecoin partner to expand its reach globally furthering its market depth.  Recently reported earnings showed growing cash reserves as shares are aggressively bought back and debt retired.  We continue to recommend a stop at $325, looking to achieve $432 - upside potential of 18%.  Yield 0.7%

(Analysts’ price target is $420.14)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate MSCI, a world leader in data tracking used in ETF indices, as a TOP PICK.  Its recent acquisition of First Street will allow its market reach to broaden further.  Cash reserves are steady as shares are aggressively bought back -- albeit with slightly increasing debt.  We recommend trailing up the stop (from $435) to $480, looking to achieve $697 -- upside potential of 23%.  Yield 1.4%  

(Analysts’ price target is $696.94)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Apr 03/25, Down 10.7%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with TLT has triggered its stop at $82.  To remain disciplined, we recommend covering the position at this time.  When combined with previous guidance, this will result in a net investment loss of 9%.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jul 30/26, Up 66.7%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with MAL has achieved its target at $42.  To remain disciplined, we recommend covering half the position at this time and trailing up the stop (from $29) to $34.  

COMMENT

He's held the hyperscalers as core holdings since 2015 and he still sees upside. The past quarter validated that with acceleration in the cloud business by Amazon, Microsoft and Google. Margins increased. But there will be more competition for AI services and prices are reducing for best-in-class models. Meta's in the doghouse from regulatory issues and are spending a lot of money but their core advertising business is on fire, which may surpass Google Shopify is using AI to accelerate its core offerings. As for software, Microsoft's Co-Pilot keeps getting better, while ServiceNow will build AI functionality across all its platforms. End users will use software they already trust, but will use AI.

DON'T BUY

He owns no engineering or construction, which have had a tough 12 months over AI fears. Prefers Stantec of Atkins. He doesn't believe the AI threats is as dire as the market fears.

BUY

A sleep at night stock. If you get 12% a year compounded, you'll be happy. The dividend will grow each year. Good management. GOod to buy this 5-6% like now. Don't expect 30-40% returns, but this will be an anchor in your portfolio.

BUY

Managed well that puts together good deals. In private equity, he prefers Blackstone which has more leverage in its business model and less exposure to the global office market, though BN owns quality office towers. BM has one advantage: it can list on the NYSE and get on the S&P which can uplift the valuation.

BUY

It focuses only on high-end New York City apartments, which has only 2% vacancy, a hot market, where rents are rising. They're trying to buy H&R REIT (which holds the sunbelt market, though a depressed one). If the deal closes, it will be good for GO. Not worried about the dividend.

DON'T BUY

Trades at 15-20x revenue, so the market expects strong growth for five years without AI disruption or hiccups. Prefers MSFT at a much-lower PE.

BUY

He likes it for water treatment business, which is stable, and it pays a nice dividend. Strong capital allocation; they got rid of convertible debentures and are buying back stock. It can compound 10-15% a year.

SELL

He has sold or taken profits from all Canadian banks after their strong run. He sold TD. Multiples are way above historic averages, given expectations of the banks returning excess capital to shareholders. The space is seeing more competition, though, like Wealthsimple.

DON'T BUY

Doesn't know what to do with this. Semis is almost a play on the cyclicality of additional leverage on the growth on semis. Shares have moved up a lot. He expects their next numbers to be very strong but these companies are not about what they will make today or tomorrow, but in 2029? The memory space has positive tailwinds as the demand for memory keeps growing, but will that outgrow capacity? MIcron's revenue looks like it will peak in 2028 then flatline. What will happen after?

PAST TOP PICK
(A Top Pick Oct 23/25, Down 7%)

It did well initially, then sold off on minor credit concerns and emerging market jitters. It's low-cost to serve their customers: cost them $1 to serve a customer but generates $15 per customer up to $30 a month. They want to expand beyond Latin America into the U.S.